These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 11091055)
1. Current and future antifungal therapy: new targets for antifungal therapy. Andriole VT Int J Antimicrob Agents; 2000 Nov; 16(3):317-21. PubMed ID: 11091055 [TBL] [Abstract][Full Text] [Related]
2. The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents. Andriole VT J Antimicrob Chemother; 1999 Aug; 44(2):151-62. PubMed ID: 10473222 [TBL] [Abstract][Full Text] [Related]
3. Current and future therapy of invasive fungal infections. Andriole VT Curr Clin Top Infect Dis; 1998; 18():19-36. PubMed ID: 9779349 [TBL] [Abstract][Full Text] [Related]
4. Is there a role for polyenes in treating invasive mycoses? Cornely OA; Vehreschild JJ; Ullmann AJ Curr Opin Infect Dis; 2006 Dec; 19(6):565-70. PubMed ID: 17075332 [TBL] [Abstract][Full Text] [Related]
5. Recent approaches to antifungal therapy for invasive mycoses. Mathew BP; Nath M ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067 [TBL] [Abstract][Full Text] [Related]
6. Management of invasive fungal infections: a role for polyenes. Chandrasekar P J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787 [TBL] [Abstract][Full Text] [Related]
8. New facets of antifungal therapy. Chang YL; Yu SJ; Heitman J; Wellington M; Chen YL Virulence; 2017 Feb; 8(2):222-236. PubMed ID: 27820668 [TBL] [Abstract][Full Text] [Related]
9. Systemic Antifungal Agents: Current Status and Projected Future Developments. Seyedmousavi S; Rafati H; Ilkit M; Tolooe A; Hedayati MT; Verweij P Methods Mol Biol; 2017; 1508():107-139. PubMed ID: 27837500 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of antifungal agents in children. Watt K; Benjamin DK; Cohen-Wolkowiez M Early Hum Dev; 2011 Mar; 87 Suppl 1(Suppl 1):S61-5. PubMed ID: 21277714 [TBL] [Abstract][Full Text] [Related]
11. Antifungals in Clinical Use and the Pipeline. Johnson MD Infect Dis Clin North Am; 2021 Jun; 35(2):341-371. PubMed ID: 34016281 [TBL] [Abstract][Full Text] [Related]
12. Systemic mycoses in the immunocompromised host: an update in antifungal therapy. Kontoyiannis DP; Mantadakis E; Samonis G J Hosp Infect; 2003 Apr; 53(4):243-58. PubMed ID: 12660121 [TBL] [Abstract][Full Text] [Related]
15. Current drug therapy of systemic mycoses: a review. Yonga G East Afr Med J; 1995 Jun; 72(6):394-8. PubMed ID: 7498014 [TBL] [Abstract][Full Text] [Related]
19. The value of amphotericin B in the treatment of invasive fungal infections. Klepser M J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541 [TBL] [Abstract][Full Text] [Related]
20. What's new in antifungals: an update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agents. Wiederhold NP; Patterson TF Curr Opin Infect Dis; 2015 Dec; 28(6):539-45. PubMed ID: 26374950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]